Life Sciences Litigation & Enforcement Team
Invidior Pays $300M to Settle Claims that it Improperly Marketed Suboxone
Life Sciences Securities Litigation ·
Cornerstone Research 2020 Report Identifies Trends In Securities Litigation Filings Affecting Life Sciences Firms
Life Sciences Securities Litigation ·
Year-End NERA Report Shows COVID-19-Related Federal Securities Litigation Disproportionately Targeting Life Sciences Firms
Life Sciences Securities Litigation ·